Cargando…

Evaluation of the Potential of p‐Boronophenylalaninol as a Boron Carrier in Boron Neutron Capture Therapy, Referring to the Effect on Intratumor Quiescent Cells

C57BL mice bearing EL4 tumors and C3H/He mice bearing SCC VII tumors received 5‐bromo‐2′‐deoxyuridine (BrdU) continuously for 5 days via implanted mini‐osmotic pumps to label all proliferating (P) cells. Three hours after oral administration of l‐p‐boronophenylalanine‐(10)B (BPA), or 30 min after in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Masunaga, Shin‐ichiro, Ono, Koji, Kirihata, Mitsunori, Takagaki, Masao, Sakurai, Yoshinori, Kinashi, Yuko, Kobayashi, Tooru, Nagasawa, Hideko, Uto, Yoshihiro, Hori, Hitoshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2001
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5926838/ https://www.ncbi.nlm.nih.gov/pubmed/11572769 http://dx.doi.org/10.1111/j.1349-7006.2001.tb01191.x

Ejemplares similares

Applicability of Combination with Tirapazamine in Boron Neutron Capture Therapy
por: Masunaga, Shin‐ichiro, et al.
Publicado: (1998)

Responses of Total and Quiescent Cell Populations in Solid Tumors to Boron and Gadolinium Neutron Capture Reaction Using Neutrons with Two Different Energy Spectra
por: Masunaga, Shin‐ichiro, et al.
Publicado: (1998)

The Effects of Boron Neutron Capture Therapy on Liver Tumors and Normal Hepatocytes in Mice
por: Suzuki, Minoru, et al.
Publicado: (2000)

Usefulness of Tirapazamine as a Combined Agent in Chemoradiation and Thermo‐chemoradiation Therapy at Mild Temperatures: Reference to the Effect on Intratumor Quiescent Cells
por: Masunaga, Shin‐ichiro, et al.
Publicado: (2000)

The Combined Effect of Electroporation and Borocaptate in Boron Neutron Capture Therapy for Murine Solid Tumors
por: Ono, Koji, et al.
Publicado: (2000)

Impact of the p53 Status of the Tumor Cells on the Effect of Reactor Neutron Beam Irradiation, with Emphasis on the Response of Intratumor Quiescent Cells
por: Masunaga, Shin‐ichiro, et al.
Publicado: (2002)

Effect of Electroporation on Cell Killing by Boron Neutron Capture Therapy Using Borocaptate Sodium ((10)B‐BSH)
por: Ono, Koji, et al.
Publicado: (1998)

Changes in the Sensitivity of Intratumor Cells during Fractionated Tirapazamine Administration
por: Masunaga, Shin‐ichiro, et al.
Publicado: (2000)

Effects of Boron Neutron Capture Therapy Using Borocaptate Sodium in Combination with a Tumor‐selective Vasoactive Agent in Mice
por: Ono, Koji, et al.
Publicado: (1998)

The impact of TP53 status of tumor cells including the type and the concentration of administered (10)B delivery agents on compound biological effectiveness in boron neutron capture therapy
por: Masunaga, Shin-ichiro, et al.
Publicado: (2023)

Augmentation in Chemosensitivity of Intratumor Quiescent Cells by Combined Treatment with Nicotinamide and Mild Hyperthermia
por: Masunaga, Shin‐ichiro, et al.
Publicado: (1997)

Evaluating the Usefulness of a Novel (10)B-Carrier Conjugated With Cyclic RGD Peptide in Boron Neutron Capture Therapy
por: Masunaga, Shin-ichiro, et al.
Publicado: (2012)

Boron neutron capture therapy outcomes for advanced or recurrent head and neck cancer
por: Suzuki, Minoru, et al.
Publicado: (2014)

Synthesis and cytotoxicity of the boron carrier pentagamaboronon-0-ol for boron neutron capture therapy against breast cancer
por: Utomo, Rohmad Yudi, et al.
Publicado: (2022)

Induced radioactivity in the blood of cancer patients following Boron Neutron Capture Therapy
por: Fujiwara, Keiko, et al.
Publicado: (2013)

Synthesis and Evaluation of Dodecaboranethiol Containing Kojic Acid (KA-BSH) as a Novel Agent for Boron Neutron Capture Therapy
por: Takeuchi, Koji, et al.
Publicado: (2020)

Sonoporation as an enhancing method for boron neutron capture therapy for squamous cell carcinomas
por: Yamatomo, Naofumi, et al.
Publicado: (2013)

Preparation of pentagamaboronon-0 and its fructose and sorbitol complexes as boron carrier for boron neutron capture therapy (BNCT) application
por: Susidarti, Ratna Asmah, et al.
Publicado: (2019)

The dependency of compound biological effectiveness factors on the type and the concentration of administered neutron capture agents in boron neutron capture therapy
por: Masunaga, Shin-ichiro, et al.
Publicado: (2014)

DNA double-strand break induction in Ku80-deficient CHO cells following Boron Neutron Capture Reaction
por: Kinashi, Yuko, et al.
Publicado: (2011)

An attempt to improve the therapeutic effect of boron neutron capture therapy using commonly employed (10)B-carriers based on analytical studies on the correlation among quiescent tumor cell characteristics, tumor heterogeneity and cancer stemness
por: Masunaga, Shin-ichiro, et al.
Publicado: (2020)

Effect of bevacizumab combined with boron neutron capture therapy on local tumor response and lung metastasis
por: MASUNAGA, SHIN-ICHIRO, et al.
Publicado: (2014)

Effects of Bioreductive Agents, Tirapazamine and Mitomycin C, on Quiescent Cell Populations in Solid Tumors, Evaluated by Micronucleus Assay
por: Masunaga, Shin‐ichiro, et al.
Publicado: (1997)

Evaluation of a novel sodium borocaptate-containing unnatural amino acid as a boron delivery agent for neutron capture therapy of the F98 rat glioma
por: Futamura, Gen, et al.
Publicado: (2017)

Synthesis, Molecular Docking, and In Vitro Boron Neutron Capture Therapy Assay of Carboranyl Sinomenine †
por: Cai, Jianghong, et al.
Publicado: (2020)

Boron-incorporating hemagglutinating virus of Japan envelope (HVJ-E) nanomaterial in boron neutron capture therapy
por: Yoneoka, Shuichiro, et al.
Publicado: (2019)

Development and Elucidation of a Novel Fluorescent Boron-Sensor for the Analysis of Boronic Acid-Containing Compounds
por: Hattori, Yoshihide, et al.
Publicado: (2017)

Antibody-Based Receptor Targeting Using an Fc-Binding Peptide-Dodecaborate Conjugate and Macropinocytosis Induction for Boron Neutron Capture Therapy
por: Nakase, Ikuhiko, et al.
Publicado: (2020)

The Anti-Proliferative Effect of Boron Neutron Capture Therapy in a Prostate Cancer Xenograft Model
por: Takahara, Kiyoshi, et al.
Publicado: (2015)

Boron-peptide conjugates with angiopep-2 for boron neutron capture therapy
por: Xiang, Jing, et al.
Publicado: (2023)

A case of radiation-induced osteosarcoma treated effectively by boron neutron capture therapy
por: Futamura, Gen, et al.
Publicado: (2014)

Boron Neutron Capture Therapy for Malignant Brain Tumors
por: MIYATAKE, Shin-Ichi, et al.
Publicado: (2016)

Theranostics in Boron Neutron Capture Therapy
por: Sauerwein, Wolfgang A. G., et al.
Publicado: (2021)

Analysis of boron neutron capture reaction sensitivity using Monte Carlo simulation and proposal of a new dosimetry index in boron neutron capture therapy
por: Takeno, Satoshi, et al.
Publicado: (2022)

Comparison of the pharmacokinetics between L-BPA and L-FBPA using the same administration dose and protocol: a validation study for the theranostic approach using [(18)F]-L-FBPA positron emission tomography in boron neutron capture therapy
por: Watanabe, Tsubasa, et al.
Publicado: (2016)

Role of p53 mutation in the effect of boron neutron capture therapy on oral squamous cell carcinoma
por: Fujita, Yusei, et al.
Publicado: (2009)

Effect of Rapamycin on the Radio-Sensitivity of Cultured Tumor Cells Following Boron Neutron Capture Reaction
por: Tatebe, Hitoshi, et al.
Publicado: (2020)

Boron microlocalization in oral mucosal tissue: implications for boron neutron capture therapy
por: Morris, G M, et al.
Publicado: (2000)

Nanostructured Boron Nitride With High Water Dispersibility For Boron Neutron Capture Therapy
por: Singh, Bikramjeet, et al.
Publicado: (2016)

Multi-Functional Boron-Delivery Agents for Boron Neutron Capture Therapy of Cancers
por: Oloo, Sebastian O., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_7om6k5ppn9un5agilqrobn567q